A detailed history of Rothschild Investment LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 90 shares of MYGN stock, worth $1,566. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Previous 35 157.14%
Holding current value
$1,566
Previous $856,000 187.97%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$23.97 - $28.6 $1,318 - $1,573
55 Added 157.14%
90 $2.47 Million
Q2 2024

Jul 30, 2024

BUY
$17.98 - $25.47 $629 - $891
35 New
35 $856,000
Q1 2024

Jul 31, 2024

SELL
$17.59 - $23.59 $439 - $589
-25 Reduced 71.43%
10 $213,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.4B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.